Main navigation

About Us
Commitments
- Innovation Hub
Products
Partnerships
- Grants
- Partnerships for the Future
News
- In The News
- Archive
Events
Investors
Careers

Home
Investors
In the News
Archive
Events

Pacira in the News

Recent News

Pacira Receives Positive CHMP Opinion for EXPAREL® (bupivacaine liposome injectable suspension) for the Treatment of Postsurgical Pain

09/18/20

IPG and Pacira BioSciences Announce Collaboration to Reduce Postsurgical Opioid Prescribing and Surgical Procedure Costs

09/15/20

Pacira BioSciences to Present at the 2020 H.C. Wainwright 22nd Annual Global Investment Conference

09/11/20

Pacira BioSciences Reports Preliminary Net Product Sales of $36.9 Million for August 2020

09/09/20

Pacira BioSciences Reports Second Quarter 2020 Financial Results and Business Update

08/06/20

Browse the press release archive

Shareholder Tools

Print Page
RSS Feeds
Email Alerts

Contact Us
Legal
Site Map
Privacy Notice

EXPAREL^® (bupivacaine liposome injectable suspension), the EXPAREL logo, iovera^o, the iovera^o logo, Pacira, and the Pacira logo are registered trademarks of Pacira BioSciences, Inc. All other trademarks referenced herein are the property of their respective owners.